ReviewFrontiers in fungal biology2025
Nanotechnology for fungal pathogen control in crops: innovations, public health impacts, and disease prevention.
Review in Frontiers in fungal biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Myco-synthesized copper oxide nanoparticles as a sustainable bionanofungicide for managing Fusarium falciforme and enhancing potato productivity.Scientific reports · 2026Article
- Mycogenic Nanomaterials: What Fungal Nanoparticles Promise and What Still Holds Them Back.Journal of fungi (Basel, Switzerland) · 2026Review
- Advances in the Control of Plant Fungal Pathogens.Journal of fungi (Basel, Switzerland) · 2026Review
- Bifunctional metal nanoparticles in agriculture: an opinion on their role as fungicides and fertilizers.Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal pathogens continue to devastate global agriculture, causing significant crop losses, compromising food security, and posing emerging threats to public health. This paper critically examines the revolutionary role of nanotechnology-driven innovations in combating fungal diseases in crops, offering an integrative framework that bridges plant health, environmental sustainability, and human well-being. We synthesize recent advancements in agricultural nanomaterials, including silver, zinc oxide, and copper oxide nanoparticles, as well as green-synthesized nanoformulations. We examine their antifungal mechanisms, including membrane disruption, induction of oxidative stress, targeted delivery, and inhibition of spore germination. The review highlights how nanosensors can facilitate early detection of pathogens, while nano-enabled packaging and innovative delivery systems prevent post-harvest contamination and extend shelf life. Crucially, we underscore the public health benefits of reduced chemical pesticide use, lowered mycotoxin exposure, and the potential for mitigating antimicrobial resistance. The paper advances the discourse on environmentally responsible, high-precision disease control strategies in agriculture by linking nanotechnology to broader sustainability goals. Furthermore, we identify key challenges, including regulatory ambiguity, ecotoxicological concerns, and barriers to equitable adoption, especially among smallholder farmers in the Global South. This paper contributes a forward-looking agenda for integrating nanotechnology into holistic pest management systems through inclusive policies, interdisciplinary research, and stakeholder-driven implementation pathways. Overall, this review positions nanotechnology as a transformative tool in reengineering crop protection paradigms that align innovation with sustainability, resilience, and public health imperatives in the face of escalating global challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.